Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can)

Annals of Hematology

Volumn 91, Issue 10, 2012, Pages 1519-1531

  Nagel, Gabriele ^a,b   Stocks, Tanja ^c,d   Späth, Daniela ^e   Hjartåker, Anette ^f   Lindkvist, Björn ^g   Hallmans, Göran ^c   Jonsson, Håkan ^c   Bjørge, Tone ^h,i   Manjer, Jonas ^j   Häggström, Christel ^c   Engeland, Anders ^h,i   Ulmer, Hanno ^k   Selmer, Randi ⁱ   Concin, Hans ^b   Stattin, Pär ^c,l   Schlenk, Richard F ^e  

^a UNIVERSITY OF ULM   (Germany)

^b AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^c UMEÅ UNIVERSITY   (Sweden)

^d The Capital Region   (Denmark)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f CANCER REGISTRY OF NORWAY   (Norway)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h UNIVERSITY OF BERGEN   (Norway)

ⁱ NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

Biomarker; Cancer; Epidemiology; Leukemia; Lymphoma

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; T CELL LYMPHOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84867336658     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1489-z     Document Type: Article

References (46)

1. Adamson P, Bray F, Costantini AS et al (2007) Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 43(2):391-401
2. Swerdlow SH, Campo E, Harris N et al (2008) WHO classification of of tumours of haematopoetic and lymphoid tissues, 4th edn. WHO, Lyon
3. Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110(2):695-708
4. Alexander DD, Mink PJ, Adami H-O et al (2007) The non- Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1-39
5. Alexander DD, Mink PJ, Adami H-O et al (2007) Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 120 (Suppl 12):40-61
6. Eckel RH, Alberti KGMM, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. Lancet 375(9710):181-183
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625-1638
8. Lichtman MA (2010) Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist 15 (10):1083-1101
9. Willett EV, Morton LM, Hartge P et al (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the interlymph consortium. Int J Cancer 122(9):2062-2070
10. Britton JA, Khan AE, Rohrmann S et al (2008) Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 93(11):1666-1677
11. Ross JA, Parker E, Blair CK, Cerhan JR, Folsom AR (2004) Body mass index and risk of leukemia in older women. Cancer Epidemiol Biomarkers Prev 13(11 Pt 1):1810-1813
12. Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadóttir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6(11):863-873
13. Chang ET, Hjalgrim H, Smedby KE et al (2005) Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97(3):210-218
14. Khan AE, Gallo V, Linseisen J et al (2008) Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition. Haematologica 93(6):842-850
15. Lim U, Gayles T, Katki HA et al (2007) Serum high-density lipoprotein cholesterol and risk of non-Hodgkin lymphoma. Cancer Res 67(11):5569-5574
16. Ulmer H, Borena W, Rapp K et al (2009) Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 101(7):1202-1206
17. Mitri J, Castillo J, Pittas AG (2008) Diabetes and risk of non- Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care 31(12):2391-2397
18. Stocks T, Borena W, Strohmaier S et al (2010) Cohort profile: the metabolic syndrome and cancer project (Me-Can). Int J Epidemiol 39(3):660-667
19. Eurostat. European shortlist for causes of death. 2009
20. Morton LM, Wang SS, Cozen W et al (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112 (13):5150-5160
21. Wood AM, White I, Thompson SG, Lewington S, Danesh J (2006) Regression dilution methods for meta-analysis: assessing longterm variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 35(6):1570-1578
22. Greenland S (2008) Multiple comparisons and association selection in general epidemiology. Int J Epidemiol 37(3):30-434
23. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9):2289-2304
24. Larsson SC, Wolk A (2008) Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 122 (6):1418-1421
25. Banker DE, Mayer SJ, Li HY et al (2004) Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 104(6):1816-1824
26. Sánchez-Martín CC, Dávalos A, Martín- Sánchez C et al (2007) Cholesterol starvation induces differentiation of human leukemia HL-60 cells. Cancer Res 67(7):3379-3386
27. Ahn J, Lim U, Weinstein SJ et al (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18(11):2814-2821
28. Strasak AM, Pfeiffer RM, Brant LJ et al (2009) Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year followup study. Ann Oncol 20(6):1113-1120
29. Casalou C, Costa A, Carvalho T et al (2011) Cholesterol regulates VEGFR-1 (FLT-1) expression and signaling in acute leukemia cells. Mol Cancer Res 9(2):215-224
30. Engeland A, Tretli S, Hansen S, Bjørge T (2007) Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 165 (1):44-52
31. Larsson SC, Wolk A (2007) Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer 121(7):1564-1570
32. Gainsford T, Willson TA, Metcalf D et al (1996) Leptin can induce proliferation, differentiation, and functional activation of hematopoietic cells. Proc Natl Acad Sci USA 93(25):14564-14568
33. Claycombe K, King LE, Fraker PJ (2008) A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci USA 105(6):2017-2021
34. Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5):1505-1522
35. Willett EV, Roman E (2006) Obesity and the risk of Hodgkin lymphoma (United Kingdom). Cancer Causes Control 17 (8):1103-1106
36. MacInnis RJ, English DR, Hopper JL, Giles GG (2005) Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 97(15):1154-1157
37. Reseland JE, Reppe S, Olstad OK et al (2009) Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma. Eur J Haematol 83(5):460-470
38. Maskarinec G, Erber E, Gill J, Cozen W, Kolonel LN (2008) Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 17(1):196-203
39. Skibola CF, Holly EA, Forrest MS et al (2004) Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13(5):779-786
40. Chang CM, Wang SS, Dave BJ et al (2010) Risk factors for non- Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/20949561. Accessed May 12, 2011
41. Cerhan JR, Bernstein L, Severson RK et al (2005) Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 16(10):1203-1214
42. Rosengren A, Himmelmann A, Wilhelmsen L, Branehög I, Wedel H (1998) Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens 16(7):933-940
43. Jee SH, Ohrr H, Sull JWet al (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194-202
44. Rousseau M-C, Parent M-E, Pollak MN, Siemiatycki J (2006) Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118(8):2105-2109
45. Freund GG, Kulas DT, Mooney RA (1993) Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. J Immunol 151(4):1811-1820
46. Qiang Y-W, Yao L, Tosato G, Rudikoff S (2004) Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood 103(1):301-308